comparemela.com

Latest Breaking News On - Falko friedrichs - Page 1 : comparemela.com

GERRESHEIMER AG : Deutsche Bank keeps its Buy rating

In a research note, Deutsche Bank analyst Falko Friedrichs has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 130.

Falko-friedrichs
Deutsche-bank

EVOTEC : Deutsche Bank maintains a Buy rating

In a research note published by Falko Friedrichs, Deutsche Bank advises its customers to buy the stock. The target price is unchanged and still at EUR 12.

Falko-friedrichs
Deutsche-bank

Evotec SE (NASDAQ:EVO) Q1 2024 Earnings Call Transcript

Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2024 Conference Call. I am Sandra, the chorus call operator.

United-states
Hamburg
Germany
United-kingdom
Italy
Switzerland
France
America
Evotec-biologics
Falko-friedrichs
Joseph-hedden
Mario-polywka

SCHOTT PHARMA : Receives a Buy rating from Deutsche Bank

Falko Friedrichs from Deutsche Bank retains his positive opinion on the stock with a Buy rating. The target price has been revised downwards and is now set at EUR 35 as compared to EUR 45 previously.

Falko-friedrichs
Deutsche-bank

SARTORIUS VORZUEGE : Deutsche Bank sticks Neutral

In a research note published by Falko Friedrichs, Deutsche Bank gives a Neutral rating to the stock. The target price differs slightly and is now set at EUR 280 versus EUR 285.

Falko-friedrichs
Deutsche-bank

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.